Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2004 | 03-2004 | 12-2003 | 09-2003 | 06-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,770 | 6,540 | 7,600 | 4,780 | 1,790 |
| Other current assets | 100 | 130 | 90 | 50 | 90 |
| TOTAL | $8,870 | $6,670 | $7,690 | $4,830 | $1,880 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 180 | 170 | 150 | 140 | 130 |
| TOTAL | $180 | $170 | $150 | $140 | $130 |
| Total Assets | $9,160 | $6,980 | $8,000 | $5,150 | $2,200 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 90 | 630 | 140 | 340 | 360 |
| Accrued Expenses | 590 | 440 | 210 | 50 | 50 |
| Other current liabilities | 10 | 50 | 20 | 2 | 0 |
| TOTAL | $690 | $1,130 | $370 | $400 | $410 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $690 | $1,130 | $370 | $400 | $410 |
| Shareholders' Equity | |||||
| Common Shares | 20 | 20 | 20 | 20 | 20 |
| Retained earnings | -15,960 | -14,560 | -12,700 | -11,130 | -9,750 |
| Other shareholders' equity | 0 | -40 | -70 | -50 | -80 |
| TOTAL | $8,470 | $5,850 | $7,620 | $4,750 | $1,790 |
| Total Liabilities And Equity | $9,160 | $6,980 | $7,990 | $5,150 | $2,200 |